Literature DB >> 11083690

Inhalation provocation tests in chronic bird fancier's lung.

Y Ohtani1, K Kojima, Y Sumi, M Sawada, N Inase, S Miyake, Y Yoshizawa.   

Abstract

BACKGROUND: Patients with chronic bird fancier's lung (BFL) can be classified into two types. One group of patients develops chronic disease with fluctuating acute episodes, including low-grade fever, mild exertional dyspnea, and cough (fluctuating chronic BFL; formerly termed recurrent and relapsing chronic BFL). The other group of patients shows no history of acute episodes (insidious chronic BFL). The diagnosis of chronic BFL is difficult, since the onset of chronic BFL may be insidious, with few if any symptoms during the early stages of the disease process. STUDY
OBJECTIVE: To attempt to diagnose the conditions of these patients more precisely, inhalation provocation tests were conducted using avian dropping extracts.
DESIGN: Retrospective chart review.
SETTING: The Tokyo Medical and Dental University Hospital in Japan. PATIENTS: Eleven patients with chronic BFL (6 with fluctuating chronic BFL and 5 with insidious chronic BFL) and 6 control subjects (4 asymptomatic bird owners and 2 idiopathic pulmonary fibrosis patients) were evaluated. MEASUREMENTS AND
RESULTS: Inhalation provocation tests using avian dropping extracts were conducted. All BFL patients were evaluated as positive or probable by inhalation challenge, whereas control subjects were evaluated as negative. A peripheral leukocytosis, an increase of alveolar-arterial oxygen pressure difference, an increase of body temperature, and the development of respiratory symptoms including cough and dyspnea were more frequently observed in chronic BFL patients than in control subjects. All the BFL patients had an increase in neutrophils in BAL fluids following inhalation challenge.
CONCLUSIONS: We validated the utility of inhalation challenge for the diagnosis of chronic BFL, including fluctuating and insidious BFL. We also demonstrated that neutrophilia in BAL fluids following inhalation challenge could be added to the diagnostic criteria for chronic BFL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083690     DOI: 10.1378/chest.118.5.1382

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

Review 1.  Bird fancier's lung: a state-of-the-art review.

Authors:  Andrew L Chan; Maya M Juarez; Kevin O Leslie; Heba A Ismail; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

Review 2.  Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.

Authors:  Margaret L Salisbury; Jeffrey L Myers; Elizabeth A Belloli; Ella A Kazerooni; Fernando J Martinez; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

Review 3.  Hypersensitivity pneumonitis.

Authors:  Ulrich Costabel; Yasunari Miyazaki; Annie Pardo; Dirk Koschel; Francesco Bonella; Paolo Spagnolo; Josune Guzman; Christopher J Ryerson; Moises Selman
Journal:  Nat Rev Dis Primers       Date:  2020-08-06       Impact factor: 52.329

4.  Clinical and molecular features of rapidly progressive chronic hypersensitivity pneumonitis.

Authors:  Yasushi Horimasu; Nobuhisa Ishikawa; Hiroshi Iwamoto; Shinichiro Ohshimo; Hironobu Hamada; Noboru Hattori; Morihito Okada; Koji Arihiro; Yuji Ohtsuki; Nobuoki Kohno
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 5.  The prevalence of "pigeon breeder's disease" in a Turkish city and review of the literature.

Authors:  Oğuz Uzun; Denizhan Kivanc Yilmaz; Ahmet Tevfik Sunter; Levent Erkan
Journal:  Lung       Date:  2011-04-19       Impact factor: 2.584

6.  Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias.

Authors:  Y Ohtani; S Saiki; M Kitaichi; Y Usui; N Inase; U Costabel; Y Yoshizawa
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

7.  Integrin α E β 7 (CD103) expression in bronchoalveolar lymphocytes of patients with hypersensitivity pneumonitis.

Authors:  Mariana Couto; Carmo Palmares; Marília Beltrão; Sofia Neves; Patrícia Mota; António Morais; Luís Delgado
Journal:  Int Arch Occup Environ Health       Date:  2014-05-30       Impact factor: 3.015

8.  Pneumomediastinum as a primary manifestation of chronic hypersensitivity pneumonitis.

Authors:  Dirk Koschel; Sabin Handzhiev; Carlos Cardoso; Axel Rolle; Olaf Holotiuk; Gert Höffken
Journal:  Med Sci Monit       Date:  2011-12

9.  Management of hypersensivity pneumonitis.

Authors:  Ioana O Agache; Liliana Rogozea
Journal:  Clin Transl Allergy       Date:  2013-02-04       Impact factor: 5.871

10.  Higher serum CCL17 may be a promising predictor of acute exacerbations in chronic hypersensitivity pneumonitis.

Authors:  Yasunari Miyazaki; Koji Unoura; Tomoya Tateishi; Takumi Akashi; Tamiko Takemura; Makoto Tomita; Naohiko Inase; Yasuyuki Yoshizawa
Journal:  Respir Res       Date:  2013-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.